Definium LSD drug goes 3 for 3 with another pivotal anxiety trial win Read more →
No more Nordisk as Novo goes it alone amid rebranding push Read more →
Roche, MediLink notch phase 3 lung cancer win but trail GSK on cross-trial survival Read more →
